Literature DB >> 16940927

Observation or laparoscopic adrenalectomy for adrenal incidentaloma? A surgical decision analysis.

Laurent Brunaud1, Electron Kebebew, Frederic Sebag, Rasa Zarnegar, Orlo H Clark, Quan-Yang Duh.   

Abstract

BACKGROUND: The optimal strategy remains controversial for adrenal incidentaloma, 4 to 6 cm in size, nonfunctioning, and without malignant imaging characteristics. A decision analysis model was used to identify relevant variables for selecting the optimal management (observation versus adrenalectomy). MATERIAL/
METHODS: Risk/benefit analysis in tertiary care center. The probabilities of each health outcome states were determined by a review of the literature from 1980 to 2002 (n=2844 patients); and from a retrospective review of experience at University of California San Francisco (UCSF).
RESULTS: The baseline probabilities of morbidity after laparoscopic unilateral adrenalectomy and a new indication developing during initial observation (hypersecretion, size increase, malignancy) were 7.8% and 3.1%, respectively. We found observation to be the preferred approach when using baseline probabilities and utilities. Laparoscopic adrenalectomy becomes the preferred approach however if: (1) The morbidity rate from laparoscopic unilateral adrenalectomy is < 3.0%, 2) The probability of a new indication developing for adrenalectomy during observation is > 7.5%, 3) A patient's perspective of observation has a utility of lower than 98.6%, and (4) A patient views having a complication from adrenalectomy is not much deleterious (utility > 88.1%).
CONCLUSIONS: This decision analysis model identifies the important variables for selecting the optimal management approach for adrenal incidentalomas. These results can be used to select the optimal management strategy based on individual patient preference and surgeon-specific complication rate.

Entities:  

Mesh:

Year:  2006        PMID: 16940927

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  6 in total

1.  Trends in adrenal surgery: institutional review of 528 consecutive adrenalectomies.

Authors:  Anja Lachenmayer; Kenko Cupisti; Achim Wolf; Andreas Raffel; Matthias Schott; Holger S Willenberg; Claus F Eisenberger; Wolfram T Knoefel
Journal:  Langenbecks Arch Surg       Date:  2012-06-22       Impact factor: 3.445

2.  Factors influencing the rising rates of adrenal surgery: analysis of a 25-year experience.

Authors:  Antonio Toniato; Isabella Boschin; Paolo Bernante; Mirto Foletto; Anna Maria Guolo; Maria Rosa Pelizzo; Giuseppe Opocher; Enzo Ballotta; Franco Mantero
Journal:  Surg Endosc       Date:  2008-07-15       Impact factor: 4.584

3.  Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.

Authors:  Lucile Gust; David Taieb; Arnault Beliard; Anne Barlier; Isabelle Morange; Catherine de Micco; Jean-François Henry; Frederic Sebag
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

4.  Results of adrenal surgery. Data of a Spanish National Survey.

Authors:  Jesús María Villar; Pablo Moreno; Joaquín Ortega; Elisabeth Bollo; César Pablo Ramírez; Nuria Muñoz; Cristina Martínez; Eduardo Domínguez-Adame; Juan Sancho; José Miguel del Pino; José Manuel Couselo; Ana Carrión; Marifé Candel; Nieves Cáceres; José María Octavio; Francisco Mateo; Lourdes Galán; José Manuel Ramia; Javier Aguiló; Francisco Herrera
Journal:  Langenbecks Arch Surg       Date:  2010-07-25       Impact factor: 3.445

5.  Adrenal schwannoma treated with laparoscopic surgery.

Authors:  Naoyoshi Onoda; Tetsuro Ishikawa; Takahiro Toyokawa; Tsutomu Takashima; Kenichi Wakasa; Kosei Hirakawa
Journal:  JSLS       Date:  2008 Oct-Dec       Impact factor: 2.172

6.  Patient-reported impacts of a conservative management programme for the clinically inapparent adrenal mass.

Authors:  Andreas Muth; Charles Taft; Lilian Hammarstedt; Lena Björneld; Mikael Hellström; Bo Wängberg
Journal:  Endocrine       Date:  2012-12-20       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.